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1 Introduction
Pivampicillin is a commonly used antibiotic in
the therapy of puerperal infections. In humans
pivampicillin is almost completely transformed
into ampicillin which is the biologically active
component. To our knowledge, only one investiga-
tion has determined the amount of an ampicillin
excreted in human milk [1]. Several reports on
concentrations of ampicillin in milk from animals
have been published [7, 8]. The object of the
present study was to determine the levels of ampi-
cillin in blood and milk of mothers in therapy
with pivampicillin and in the blood of their suck-
ling infants thereby estimating the dose a neonate
may receive. Also, we have analyzed blood and
milk samples from 4 mothers for a longer period
in an attempt to find a time when levels in plasma
and milk reached an equilibrium. Finally, we have
calculated the milk-plasma (M/P) ratio and the
degree of protein binding of ampicillin in milk.
2 Material and methods
Fourteen mothers with puerperal infections re-
quiring antibiotic treatment gave informed con-
sent to participate. Nine mothers receiving pivam-
picillin tablets 350 mg t. d. s. had blood sampled
2 and 4 hours after the last tablet and at breast
feeding. Three mothers receiving pivampicillin
tablets 350 mg t. d. s. and two mothers receiving
700 mg t.d. s. had blood sampled immediately
before medication and then every half hour for 2
hours and every one hour for 4 to 6 hours after
medication.
Milk samples were collected during feeding. One
hour later a blood sample was drawn from the
infants.
Medication was started from 0 to 22 days after
parturition and no sample collected until at least
24 hours after start of pivampicillin therapy. All
mothers received metronidazole tablets 200 mg
t. d. s. during the test period, but no other medica-
tion.
All samples were analyzed by microbiologic
method [2], the lower limit of detection being
0.03 g/ml. The test bacteria were not sensitive to
metronidazole. A non-specific antibiotic inhibi-
tion was observed in the milk, but it was elimin-
ated by dilution.
Ampicillin was added to four milk samples from
non-medicated mothers. Two concentrations, i. e.
0.3 g/ml and 3 g/ml, were used and levels in
the ultra filtrate were measured. The amount of
recovered free antibiotic was then determined.
When the study was commenced, no ethical com-
mittee was operative in the area.
3 Results
Concentrations of ampicillin in blood and milk
from 9 mothers are shown in table I. Concentra-
tions from 5 mothers, who had samples collected
for a longer period, are shown in table II.
No antibacterial activity was observed in any of
the infant blood samples, i.e. all samples con-
tained less than 0.03 g ampicillin per ml blood.
1987 by Walter de Gruyter & Co. Berlin · New York
556 Branebjerg & Heisterberg, Blood and milk concentrations of ampicillin
Table I. Plasma and milk levels ^g/ml) of ampicillin
and milk-plasma (M/P) ratios in 9 women in therapy
with pivampicillin 350 mg t. d. s.; time after medication
in minutes.
Patient
1
2
3
4
5
6
7
8
9
Plasma
Time
260
255
60
60
140
130
260
270
250
Level
1.10
0.78
8.20
1.10
4.00
2.70
0.33
0.51
0.45
Milk
Time
260
255
60
60
140
130
260
270
250
Level
0.10
0.06
0.08
0.17
0.11
0.06
0.19
0.07
0.06
M/P
0.09
0.07
0.01
0.15
0.03
0.02
0.58
0.14
0.13
Maximum concentrations in plasma are reached
60 to 120 minutes after oral intake of pivampicil-
lin. In milk, maximum levels are reached 180 to
240 minutes after medication. There is most likely
a significant delay before a balance between levels
in blood and milk is reached. This delay is esti-
mated to be 100 to 180 minutes. When the balance
is obtained, levels in milk seem to vary very little.
The milk-plasma (M/P) ratio is normally calcu-
lated on the basis of simultaneous samples from
blood and milk. Such a calculation gives a wide
range, i. e. 0.01-0.58, of M/P values (table I).
The recovery rate of ampicillin in the ultra filtrate
was 94 to 105%. As the variance of analysis with
this method is 5 —10%, ampicillin is found not to
be bound to protein in human milk.
4 Discussion
Administration of drugs to lactating mothers al-
ways raises the question of a possible harmful
effect of the drug on the suckling infant. The
excretion of drugs from plasma to milk is by
most believed to take place by passive diffusion
controlled by the difference in plasma and milk
pH and by protein binding in plasma and milk
[3].
Drugs, which have a high degree of protein bind-
ing in plasma, have been shown not to pass into
milk [4]. Drugs, which are neutrally reacting or
with a small molecular weight, pass freely into
milk and are found in equal concentrations in
plasma and milk [4].
Most drugs are either weak acids or weak bases.
As pH in milk is 6.85 and in plasma 7.4, weak
bases will concentrate in milk and weak acids will
occur in lower concentrations than in plasma [3].
Ampicillin is an ampholyte with two pKa values,
2.7 and 7.2 at pH 7.O. As a consequence it will
mainly be acting as a weak acid and the significant
pKa value will be 2.7. Using a modification of the
Hasselbalch-Henderson equation [3] and with pH
for milk and plasma being 6.85 and 7.4, respec-
tively, M/P ratio can be calculated to be 0.28.
The basis for the above calculation is an equili-
brium between milk and plasma levels. This is not
Table Π. Plasma and milk levels (μ§/ηι1) of ampicillin in 3 women (A, B, C) receiving pivampicillin 350 mg t. d. s.
and in 2 women (D, E) receiving 700 mg t. d. s.; time after medication in minutes.
Patient
A
Β
C
D
E
Level
Level
Level
Level
Level
Level
Level
Level
Level
Level
plasma
milk
plasma
milk
plasma
milk
plasma
milk
plasma
milk
Time
0
0.04
0.044
0.060
0.040
0.36
0.11
9.23
0.25
2.88
0.32
30
2.04
0.048
3.04
0.034
0.61
0.13
0.35
5.42
0.33
60
3.28
0.058
3.57
0.049
1.42
0.11
12.26
0.55
8.28
0.32
90
1.89
0.076
2.75
0.049
120 180
1.94
0.072
2.60
0.11
13.83
0.55
6.65
0.38
3,
0.
.92
.34
1.42
0.11
5.07
1.02
1.55
0.40
240 300
0.25 0.12
0.074 0.061
0.37
0.082 0.067
0.79
0.13
2.09 1.40
0.80 0.64
0.79
0.41
360
0.06
0.061
0.09
0.060
0.74
0.65
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obtained during normal therapeutic medication as
ampicillin has a half life of 2 hours. This explains
the time difference in maximum levels in milk and
plasma.
From our findings that the ampicillin protein
binding in milk is 0 and the one in plasma is
reported to be 18% [4], the M/P ratio must be
reduced to 0.23. The discrepancy with our result
of an M/P ratio at 0.10 (average of M/P values
in table I) is probably due to the fact that an
equilibrium is never obtained because of decreas-
ing levels of ampicillin in plasma. From the only
previous report on ampicillin excretion in human
milk [1] can be found M/P ratios varying between
0.02 and 3.0 with a mean of 0.3. Dosage was 500
mg ampicillin every 6 hours and milk and blood
were sampled simultaneously. M/P ratios reported
for other penicillins are in accordance with our
findings [6].
The daily maximum ampicillin dose an infant has
received from a mother in the present study as-
suming a milk consumption of 500 ml per day has
been 500 ml 1.02 ^g/ml = 0.5 mg (table II).
This amount is insignificant and cannot explain
reported incidents of diarrhoea and candidiasis in
suckling infants whose mothers received ampicil-
lin [5].
Allergic erythema has not been reported in suck-
ling infants, but sensibilization even with a low
dose of ampicillin is possible and should be kept
in mind.
Abstract
The levels of ampicillin were determined in milk and
plasma of 14 lactating mothers in treatment with pivam-
picillin for puerperal infections and in plasma of their
suckling infants.
Ampicillin could not be detected in plasma of the in-
fants, i. e. all levels were less than 0.03 g/ml. Maximum
levels occurred in plasma 60—120 minutes and in milk
180 — 240 minutes after medication. Milk-plasma ratios
varied between 0.01 and 0.58. The highest level of ampi-
cillin in milk was 1.02 §/ 1 in a woman receiving
pivampicillin tablets 700 mg t. d. s. At this level an infant
can at the most ingest 0.5 mg/day. This dose is too small
to cause any symptoms in the suckling infants, but
allergic sensibilization through the milk is possible.
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Zusammenfassung
Konzentration von Ampicillin in Blut und Much bei mit
Pivampicillin behandelten Muttern und bei ihren Kindern
Im Plasma und in der Milch von 14 stillenden Müttern,
die wegen einer Wochenbettinfektion mit Pivampicillin
behandelt wurden, und im Plasma ihrer Säuglinge wurde
der Ampicillin-Gehalt bestimmt.
Im Plasma der Kinder wurde kein Ampicillin gefunden;
d.h. alle Werte lagen unter 0,03 g/ml. Höchstwerte
traten im Plasma 60-120 Min. und in der Milch 180-
240 Min. nach der Medikation auf. Das Milch-Plasma-
Verhältnis variierte zwischen 0,01 und 0,58. Der höchste
Ampicillin-Wert in der Milch mit 1,02 g/ml wurde bei
einer Frau gefunden, die Pivampicillin Tabletten 700 mg
3 tägl. erhielt. Bei dieser Menge kann ein Kind bis zu
0,5 mg pro Tag aufnehmen. Die Dosis ist jedoch zu
klein, um bei dem Säugling Symptome hervorzurufen;
eine allergische Sensibilisierung durch die Milch ist aber
möglich.
Schlüsselwörter: Ampicillin, kindliche Dosis, Laktation, Milch-Werte, Pivampicillin, Plasma-Werte, Proteinbin-
dung.
Resume
Concentration d'ampicilline dans le sang et le lait des
meres traitees par pivampicilline et concentration chez
leurs enfants
On a dose les taux d'ampicilline dans le lait et le plasma
de 14 meres en cours d'allaitement, traitees par pivampi-
cilline pour infections puerperales, ainsi que dans le
plasma de leurs enfants nourris au sein.
L'ampicilline n'a pas pu etre detectee dans le plasma des
enfants, c'est-a-dire que tous les taux etaient inferieurs
ä 0,03 g/ml. Apres la prise medicamenteuse les taux
maximum s'observent dans le plasma entre 60 to 120
minutes et dans le lait entre 180 et 240 minutes. Les
rapports entre le lait et le plasma varient entre 0,01 et
0,58. Le taux le plus eleve d'ampicilline dans le lait a
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ete de 1,02 g/ ll chez une patiente prenant des gelules provoquer quelque Symptome que ce soit chez un enfant
d'ampicilline ä 700 mg. A ce taux un enfant peut recevoir nourri au sein, mais une sensibilisation allergique via le
au plus 0,5 mg par jour. Cette dose est trop faible pour lait est possible.
Mots-cles: Allaitement, ampicilline, dosage chez l'enfant, pivampicilline, proteine de transport, taux dans le lait,
taux plasmatique.
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